dr. E.H. Ploumen MD (Eline)

Medicine & Life Sciences

# Drug-Eluting Stents
# Everolimus
# Myocardial Infarction
# Percutaneous Coronary Intervention
# Prediabetic State
# Sirolimus
# Stents
# Zotarolimus

Faculty of Behavioural, Management and Social Sciences (BMS), Health Technology & Services Research (HTSR)

Pinxterhuis, T. H. , Ploumen, E. H., van Vliet, D., van Houwelingen, K. G., Stoel, M. G., de Man, F. HAF. , Hartmann, M. , Zocca, P., Linssen, G. CM. , Geelkerken, R. H. , Doggen, C. JM. , & von Birgelen, C. (2024). Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease. Atherosclerosis, 392, Article 117488. https://doi.org/10.1016/j.atherosclerosis.2024.117488

Pinxterhuis, T. H. , von Birgelen, C. , Geelkerken, R. H. , Doggen, C. J. M., Menting, T. P., van Houwelingen, K. G., Linssen, G. C. M. , & Ploumen, E. H. (2024). Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting. Cardiovascular Intervention and Therapeutics, 39(2), 173-182. https://doi.org/10.1007/s12928-024-00986-7

van Dijk, S. H. B. , Brusse-Keizer, M. G. J., Bucsán, C. C. , Ploumen, E. H., van Beurden, W. , van der Palen, J. , Doggen, C. , & Lenferink, A. (2024). Lack of Evidence Regarding Markers Identifying Acute Heart Failure in Patients with COPD: An AI-Supported Systematic Review. International journal of chronic obstructive pulmonary disease, 19, 531-541. https://doi.org/10.2147/COPD.S437899

van dijk, S. H. B. , Brusse-Keizer, M. G. J., Bucsán, C. C. , Ploumen, E. H., van Beurden, W. J. C. , van der Palen, J. , Doggen, C. J. M. , & Lenferink, A. (2023). Biomarkers differentiating acute heart failure from COPD exacerbations: not much evidence. European respiratory journal, PA515. https://doi.org/10.1183/13993003.congress-2023.PA515

van dijk, S. H. B. , Brusse-Keizer, M. G. J. , Effing, T., van der valk, P. D. L. P. M. , Ploumen, E. H. , van der Palen, J. , Doggen, C. J. M. , & Lenferink, A. (2023). Exploring patterns of COPD exacerbations and comorbid flare-ups. European respiratory journal, PA1348. https://doi.org/10.1183/13993003.congress-2023.PA1348

van Dijk, S. H. B. , Brusse-Keizer, M. , Effing, T., van der Valk, P. D. L. P. M. , Ploumen, E. , Palen, J. V. D. , Doggen, C. J. M. , & Lenferink, A. (2023). Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups. International journal of chronic obstructive pulmonary disease, 18, 2633-2644. https://doi.org/10.2147/COPD.S428960

ULTRA Collaborators (2023). Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry. Catheterization and cardiovascular interventions, 102(2), 221-232. https://doi.org/10.1002/ccd.30696

Pinxterhuis, T. H. , Ploumen, E. H. , Zocca, P. , Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A. , Hartmann, M., Linssen, G. C. M. , & von Birgelen, C. (2023). Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention. Frontiers in Cardiovascular Medicine, 10, Article 1160201. https://doi.org/10.3389/fcvm.2023.1160201

Pinxterhuis, T. H. , Ploumen, E. H. , Zocca, P. , Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., van Houwelingen, K. G., Linssen, G. C. M. , Geelkerken, R. H. , & von Birgelen, C. (2023). Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials. Cardiovascular diagnosis and therapy, 13(4), 673-685. https://doi.org/10.21037/cdt-22-584

Pinxterhuis, T. H. , Ploumen, E. H. , Doggen, C. J. M. , Hartmann, M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Linssen, G. C. M. , & Von birgelen, C. (2023). First Myocardial Infarction in Patients with Premature Coronary Artery Disease: Insights into Patient Characteristics and Outcome after Treatment with Contemporary Stents. European Heart Journal: Acute Cardiovascular Care, 12(11), 774-781. https://doi.org/10.1093/ehjacc/zuad098

Pinxterhuis, T. H. , Ploumen, E. H. , Zocca, P. , Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Stoel, M. G., Linssen, G. C. M. , Geelkerken, R. H. , & von Birgelen, C. (2023). Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease. International journal of cardiology, 374, 27-32. https://doi.org/10.1016/j.ijcard.2022.12.009

Ploumen, E. H., Pinxterhuis, T. H., Buiten, R. A. , Zocca, P., Danse, P. W., Schotborgh, C. E., Scholte, M., Tjon Joe Gin, R. M., Somi, S., van Houwelingen, K. G., Stoel, M. G., de Man, H. A. F. , Hartmann, M., Linssen, G. C. M. , van der Heijden, L. C. , Kok, M. M. , Doggen, C. J. M. , & von Birgelen, C. (2022). Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers. Journal of the American Heart Association, 11(22), Article e026041. https://doi.org/10.1161/JAHA.122.026041

Ploumen, E. H. , & von Birgelen, C. (2022). Search for Holy Grail of Stent Coating Will Go On. Cardiovascular Revascularization Medicine, 42, 100-101. https://doi.org/10.1016/j.carrev.2022.06.019

Burrello, J., Gallone, G., Burrello, A., Pagliari, D. J. , Ploumen, E. H., Iannaccone, M., De Luca, L. , Zocca, P., Patti, G., Cerrato, E., Wojakowski, W., Venuti, G., De Filippo, O., Mattesini, A., Ryan, N., Helft, G., Muscoli, S., Kan, J., Sheiban, I., ... D’ascenzo, F. (2022). Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms. Journal of Personalized Medicine, 12(6), Article 990. https://doi.org/10.3390/jpm12060990

Pinxterhuis, T. H. , Ploumen, E. H. , Zocca, P. , Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Stoel, M. G., Linssen, G. C. M. , Geelkerken, R. H. , & von Birgelen, C. (2022). Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials. Atherosclerosis, 355, 52-59. https://doi.org/10.1016/j.atherosclerosis.2022.05.002

Ploumen, E. H. , Halfwerk, F. R., van der Kolk, R. , Grandjean, J. G. , von Birgelen, C. , & van Til, J. A. (2022). Use of the left radial artery as vascular access for coronary angiography and as a bypass conduit: A clinical dilemma? Cardiovascular Revascularization Medicine, 34, 134-139. https://doi.org/10.1016/j.carrev.2021.01.014

Ploumen, E. , Zocca, P., Buiten, R. A. , Doggen, C., Aminian, A., Schotborgh, C., Jessurun, G. A. J., Roguin, A., Danse, P. W., Benit, E. , & von Birgelen, C. (2021). Three-year outcome of all-comer patiens treated with resolute onyx zotarolimus-eluting versus orsiro sirolimus-eluting stens in the randomized bionyx trial. Journal of the American College of Cardiology, 77(18), 1026-1026.

Ploumen, E. H., Pinxterhuis, T. H. , Zocca, P., Roguin, A., Anthonio, R. L., Schotborgh, C. E., Benit, E., Aminian, A., Danse, P. W. , Doggen, C. J. M. , von Birgelen, C. , & Kok, M. M. (2021). Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials. Cardiovascular diabetology, 20(1), Article 217. https://doi.org/10.1186/s12933-021-01405-4

Ploumen, E. H. (2021). New-generation drug-eluting stents in various patient populations. [PhD Thesis - Research external, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789036552523

von Birgelen, C. , & Ploumen, E. H. (2021). Similar long-term outcome of dissimilar drug-eluting stents: Is it time to change the assessment? EuroIntervention, 16(18), E1468-E1469. https://doi.org/10.4244/EIJV16I18A266

Ploumen, E. H., Buiten, R. A. , Zocca, P. , Doggen, C., Aminian, A., Schotborgh, C. E., Jessurun, G. A. J., Roguin, A., Danse, P. W., Benit, E. , & von Birgelen, C. (2021). First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial. Circulation Journal, 85(11), 1983-1990. https://doi.org/10.1253/circj.cj-21-0292

Ploumen, E. H. , & von Birgelen, C. (2021). Novel DES aims at full thromboresistance: Another promising player on the field? Cardiovascular Revascularization Medicine, 32, 25-26. https://doi.org/10.1016/j.carrev.2021.07.029

Ploumen, E. H., Buiten, R. A. , Zocca, P. , Doggen, C., Jessurun, G. A. J., Schotborgh, C. E., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Anthonio, R. L., Somi, S., Linssen, G. C. M. , Hartmann, M. , Kok, M. M. , & von Birgelen, C. (2021). Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial. Catheterization and cardiovascular interventions, 98(2), E188-E196. https://doi.org/10.1002/ccd.29594

Pinxterhuis, T. H. , Ploumen, E. H. , Zocca, P., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A. , & von Birgelen, C. (2021). Peripheral arterial disease as risk factor of unfavourable outcome following coronary stenting: Analysis of pooled patient-level data from 4 randomised drug-eluting stent trials in all-comers. Poster session presented at EuroPCR 2021, Virtual Event. https://eposter.europa-organisation.com/2021/europcr/index/slide/abstract/144

Ploumen, E. H., Buiten, R. A. , Kok, M. M. , Doggen, C. J. M., Roguin, A., Jessurun, G. A. J., Schotborgh, C. E., Danse, P. W., Benit, E., Aminian, A., van Houwelingen, K. G., Stoel, M. G., Scholte, M. , Hartmann, M., Linssen, G. C. M. , Zocca, P. , & von Birgelen, C. (2021). Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials. International journal of cardiology, 325, 37-44. https://doi.org/10.1016/j.ijcard.2020.10.051

Bekijk alle publicaties van deze medewerker

+31534896370

e.h.ploumen@utwente.nl

Bezoekadres

Universiteit Twente
Faculty of Behavioural, Management and Social Sciences
Ravelijn (gebouwnr. 10), kamer Flex
Hallenweg 17
7522NH Enschede

Navigeer naar locatie

Postadres

Universiteit Twente
Faculty of Behavioural, Management and Social Sciences
Ravelijn Flex
Postbus 217
7500 AE Enschede

Faculty of Behavioural, Management and Social Sciences (BMS), Health Technology & Services Research (HTSR)

Universiteit Twente Drienerlolaan 5
7522 NB Enschede

+31 (0)53 489 9111
info@utwente.nl
Route

Welkom...

Gast Onderzoeker

Expertises

Verbonden aan

Publicaties

Pure Link

Contactgegevens

Bezoekadres

Postadres

Verbonden aan